Location# 009 — Chicago, Illinois

Location# 009 is a clinical research site located in Chicago, Illinois, United States 60611-2927.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Location# 009 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Colorectal Cancer.

Sponsors: Enzon Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

• The University of Chicago Medicine Duchossois Center for Advanced Medicine
• Jeffrey Kramer, MDSC at Mercy Hospital
• University Consultants in Allergry and Immunology
• Rush University Med Ctr
• University of Illinois Medical Center in Chicago
• University of Chicago Medical Center (UCMC) Center for Advanced Medicine (CAM)
• Rush University Medical Center-Orthopedic Spine
• Northestern University
• University of Chicao
• Rush University Medical Center - Department Of Cardiology
• Northwestern University Diagnostic Testing Center
• University of Illinois Chicago

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Location# 009?

Location# 009 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Location# 009 conducted?

Location# 009 has 1 clinical trials on record. Their work covers Metastatic Colorectal Cancer.

Is Location# 009 accredited by Crixeo Clinical Trials?

Location# 009 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Location# 009?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.